SIMILASAN Rhume glob 15 g

7680508920357 CH-50892 20.01.1.
SIMILASAN Rhume glob 15 g
SIMILASAN Rhume glob 15 g
1 / 2
google

Details

Product number
5089201
CPT
-
Packaging group
15
Unit
g
Composition
luffa operculata (HAB) D6 8.5 mg, luffa operculata (HAB) D12 1.0 mg, luffa operculata (HAB) D15 0.5 mg, calcii carbonas, xylitolum 600 mg, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Schnupfen, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/11/2023
Patient information leaflet
Français
15/11/2023
Patient information leaflet
Italien
15/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
8.5 MG Substance Wirkstoff (Principe actif)
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
600.0 MG Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
50892
Drug name
Similasan Schnupfen, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
17/10/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Trockenem oder fliessendem Schnupfen, oft mit Druck in der Stirne oder in den Kieferhöhlen; Schnupfen mit Krustenbildung in der Nase; Heuschnupfen mit Stirnkopfschmerz; Trockenen Reizzuständen der Nase

Packaging details

Description (FR)
SIMILASAN Rhume glob 15 g
Description (DE)
SIMILASAN Schnupfen Glob 15 g
Market launch
17/10/1991
Narcotic (BTM)
No

Other packaging sizes